Comprehensive analysis of m5C-related lncRNAs in the prognosis and immune landscape of hepatocellular carcinoma
Q Lu, L Liu, S Wang, Q Zhang, L Li - Frontiers in Genetics, 2022 - frontiersin.org
5-Methyladenosine (m5C) is a type of epigenetic modification involved in the progression of
various cancers. To investigate the role of m5C-related long non-coding RNAs (lncRNAs) in …
various cancers. To investigate the role of m5C-related long non-coding RNAs (lncRNAs) in …
Identification and validation of a prognostic prediction model of m6A regulator-related LncRNAs in hepatocellular carcinoma
C Jin, R Li, T Deng, J Li, Y Yang, H Li… - Frontiers in Molecular …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is a highly invasive malignancy prone to recurrence, and
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
patients with HCC have a low 5-year survival rate. Long non-coding RNAs (lncRNAs) play a …
Expression and prognostic signatures of m6A-related lncRNAs in hepatocellular carcinoma
K Hao, J Li, Y Zhang, W Zhao, X Chen, J Xu… - Journal of Cancer …, 2023 - Springer
Abstract Background N6-methyladenosine (m6A) is a common modification and plays an
important role in various biological processes, but m6A-related lncRNA functions in …
important role in various biological processes, but m6A-related lncRNA functions in …
Implications of m6A-associated snRNAs in the prognosis and immunotherapeutic responses of hepatocellular carcinoma
Background Hepatocellular carcinoma (HCC) is the most prevalent pathological type of liver
cancer worldwide with high mortality and poor prognosis. N6-methyladenosine (m6A) can …
cancer worldwide with high mortality and poor prognosis. N6-methyladenosine (m6A) can …
Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental …
T Wang, Z Zhou, X Wang, L You, W Li, C Zheng… - Frontiers in …, 2022 - frontiersin.org
Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
Prognostic signature and tumor immune landscape of N7-methylguanosine-related lncRNAs in hepatocellular carcinoma
W Wei, C Liu, M Wang, W Jiang, C Wang… - Frontiers in …, 2022 - frontiersin.org
Despite great advances in the treatment of liver hepatocellular carcinoma (LIHC), such as
immunotherapy, the prognosis remains extremely poor, and there is an urgent need to …
immunotherapy, the prognosis remains extremely poor, and there is an urgent need to …
[HTML][HTML] Comprehensive analysis of N6-methyladenosine-related lncRNAs reveals distinct hepatocellular carcinoma subtypes with immunotherapeutic implications
X Xie, H Liang, Q Ruan, X Ma, C Xie, Z Luo… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Accumulating studies have demonstrated critical roles of N6-methyladenosine (m6A)
modification and long noncoding RNAs (lncRNAs) in the biological processes leading to …
modification and long noncoding RNAs (lncRNAs) in the biological processes leading to …
Comprehensive analysis of N6-methyladenosine-related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma
ZL Yu, ZM Zhu - Bioengineered, 2021 - Taylor & Francis
We aimed to illustrate the influence of N6-methyladenosine (m6A) long non-coding RNAs
(lncRNAs) and immune cell infiltration in hepatocellular carcinoma (HCC). The relationship …
(lncRNAs) and immune cell infiltration in hepatocellular carcinoma (HCC). The relationship …
Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma
YL Peng, YF Dong, LL Guo, MY Li, H Liao, RS Li - Plos one, 2023 - journals.plos.org
Background N7-methylguanosine (m7G) is one of the most common RNA posttranscriptional
modifications; however, its potential role in hepatocellular carcinoma (HCC) remains …
modifications; however, its potential role in hepatocellular carcinoma (HCC) remains …
Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs
Y Dai, Y Gao, L Chen, J Liu, C Zeng, J Zhou… - Frontiers in …, 2022 - frontiersin.org
Background: Hepatocellular carcinoma (HCC), which has high rates of recurrence and
metastasis and is the main reason and the most common tumor for cancer mortality …
metastasis and is the main reason and the most common tumor for cancer mortality …
相关搜索
- comprehensive analysis hepatocellular carcinoma
- immune landscape hepatocellular carcinoma
- comprehensive analysis n6 methyladenosine
- n7 methylguanosine hepatocellular carcinoma
- identification and validation hepatocellular carcinoma
- comprehensive analysis immune landscape
- comprehensive analysis cell infiltration
- rna signature hepatocellular carcinoma
- cell infiltration hepatocellular carcinoma
- prognosis factors hepatocellular carcinoma
- comprehensive analysis prognosis factors
- n6 methyladenosine hepatocellular carcinoma
- prognosis factors immune microenvironment
- immunotherapeutic responses hepatocellular carcinoma
- n7 methylguanosine immune landscape
- comprehensive analysis immunotherapeutic implications